{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:01:58Z","timestamp":1791925318203,"version":"4.3.4"},"reference-count":40,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T00:00:00Z","timestamp":1368489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2013,6]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To report a case of subtherapeutic linezolid concentrations in a patient with morbid obesity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CASE SUMMARY:<\/jats:title>\n                    <jats:p>\n                      A 34-year-old male with morbid obesity (265 kg, body mass index 82 kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ) was admitted for severe sepsis due to respiratory failure requiring emergent intubation and treatment of community-acquired pneumonia. Admission tracheal aspirate culture revealed methicillin-resistant Staphylococcus aureus (MRSA) for which vancomycin was prescribed. Therapy subsequently was changed to linezolid, because the patient's clinical status worsened, with significant hypoxia (partial pressure of arterial oxygen\/fraction of inspired oxygen [PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ] ratio 145), increasing leukocytosis (white blood cell count from 10,800\/ \u03bcL on admission to 15,400\/ \u03bcL on hospital day 6), and persistent fever (38.3 \u00b0C). After 48 hours of linezolid monotherapy, the patient remained febrile with continued leukocytosis, worsening hypoxemia, and a persistently positive MRSA culture from a repeat endotracheal aspirate. Linezolid serum concentrations were obtained and vancomycin was reinstituted, after which the patient began to improve (afebrile, improving PaO\n                      <jats:sub>2<\/jats:sub>\n                      \/FiO\n                      <jats:sub>2<\/jats:sub>\n                      ratio, decreasing leukocytosis). On hospital day 12, the patient removed his endotracheal tube, and a sputum sample was obtained for culture. The patient's clinical status subsequently declined, prompting addition of cefepime to his antibiotic regimen. This sputum culture revealed not only MRSA, but also quinolone-resistant Escherichia coli. After completing treatment for both organisms the patient was discharged home.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DISCUSSION:<\/jats:title>\n                    <jats:p>Limited data on linezolid dosing in the morbidly obese population show lower serum drug concentrations than those in nonobese patients, but no clinical failure has been reported when treating MRSA skin and soft tissue infections or MRSA tracheitis. In our patient, low steady-state linezolid serum concentrations (peak 4.13 \u03bcg\/mL [reference 15-27] and trough 1.27 \u03bcg\/mL [reference 2-9]) were thought to contribute to his poor clinical response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>To our knowledge, this is the first report of subtherapeutic linezolid concentrations correlated with decreased clinical effectiveness when during treatment of MRSA pneumonia in a patient with morbid obesity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1345\/aph.1r707","type":"journal-article","created":{"date-parts":[[2013,5,15]],"date-time":"2013-05-15T00:33:24Z","timestamp":1368578004000},"page":"e25-e25","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":24,"title":["Subtherapeutic Linezolid Concentrations in a Patient with Morbid Obesity and Methicillin-Resistant\n                    <i>Staphylococcus aureus<\/i>\n                    Pneumonia: Case Report and Review of the Literature"],"prefix":"10.1177","volume":"47","author":[{"given":"Katie M","family":"Muzevich","sequence":"first","affiliation":[{"name":"Katie M Muzevich PharmD BCPS, Clinical Pharmacy Specialist, Critical Care; Clinical Assistant Professor, Department of Pharmacy Services, Virginia Commonwealth University Health System, Richmond"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly B","family":"Lee","sequence":"additional","affiliation":[{"name":"Kimberly B Lee PharmD BCPS, Clinical Pharmacy Specialist, Antimicrobial Stewardship Program; Clinical Assistant Professor, Department of Pharmacy Services, Virginia Commonwealth University Health System"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2013,5,14]]},"reference":[{"key":"bibr1-aph.1R707","volume-title":"Zyvox (linezolid)","author":"Package information","year":"2012"},{"key":"bibr2-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciq146"},{"key":"bibr3-aph.1R707","volume-title":"National Center for Health Statistics data brief, no 82","author":"Ogden CL","year":"2012"},{"key":"bibr4-aph.1R707","unstructured":"Sturm R, Hattori A. Morbid obesity rates continue to rise rapidly in the United States. Int J Obes (Lond) 2012. doi: 10.1038\/ijo.2012.159; 10.1038\/ijo.2012.159"},{"key":"bibr5-aph.1R707","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp100086"},{"key":"bibr6-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.8.1081"},{"key":"bibr7-aph.1R707","doi-asserted-by":"publisher","DOI":"10.2165\/11318100-000000000-00000"},{"key":"bibr8-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100381"},{"key":"bibr9-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2011.570331"},{"key":"bibr10-aph.1R707","doi-asserted-by":"publisher","DOI":"10.2165\/11599410-000000000-00000"},{"key":"bibr11-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccc.2010.07.003"},{"key":"bibr12-aph.1R707","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp100226"},{"key":"bibr13-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1E484"},{"key":"bibr14-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/62.5.464a"},{"key":"bibr15-aph.1R707","doi-asserted-by":"publisher","DOI":"10.3109\/00365548.2011.652164"},{"key":"bibr16-aph.1R707","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Second Informational Supplement","author":"CLSI","year":"2012"},{"key":"bibr17-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.9.3676-3681.2005"},{"key":"bibr18-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr072"},{"key":"bibr19-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440360129015"},{"key":"bibr20-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis022"},{"key":"bibr21-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1562"},{"key":"bibr22-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00133-06"},{"key":"bibr23-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1007\/BF03256610"},{"key":"bibr24-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.4.938"},{"key":"bibr25-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.5.1475-1480.2002"},{"key":"bibr26-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-003-2088-1"},{"key":"bibr27-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1185\/03007990903512057"},{"key":"bibr28-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir895"},{"key":"bibr29-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1021\/jm800038g"},{"key":"bibr30-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkf066"},{"key":"bibr31-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.2.548-553.2003"},{"key":"bibr32-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01453-12"},{"key":"bibr33-aph.1R707","doi-asserted-by":"publisher","DOI":"10.2165\/11319960-000000000-00000"},{"key":"bibr34-aph.1R707","doi-asserted-by":"publisher","DOI":"10.2174\/138920009787048446"},{"key":"bibr35-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm431"},{"key":"bibr36-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.418-420.2003"},{"key":"bibr37-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg160"},{"key":"bibr38-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1086\/511159"},{"key":"bibr39-aph.1R707","first-page":"106","volume":"21","author":"Hannan A","year":"2009","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"bibr40-aph.1R707","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2010.06.006"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1R707","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1345\/aph.1R707","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1345\/aph.1R707","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:12:55Z","timestamp":1777374775000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1345\/aph.1R707"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,14]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["10.1345\/aph.1R707"],"URL":"https:\/\/doi.org\/10.1345\/aph.1r707","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,14]]}}}